Physician profile
Andrea Darnell
NPI 1760829618
$1,592.91
in general payments reported to CMS, 2019-2025
15 companies · $89.40 in 2025
The $89.40 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $185 · 2021: $149 · 2022: $398 · 2023: $33.01 · 2024: $21.83 · 2025: $89.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $270.49 | 2019 | |
| Amgen INC. | $261.85 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $199.98 | 2022 | |
| Glaxosmithkline, LLC. | $165.66 | 2021-2025 | Shingrix, Arexvy |
| Amarin Pharma, INC. | $127.48 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $99.48 | 2022 | |
| Lilly USA, LLC | $98.27 | 2022 | |
| Novo Nordisk INC | $88.35 | 2019-2023 | Wegovy |
| Merck Sharp & Dohme LLC | $75.64 | 2019-2021 | |
| Pfizer INC. | $32.28 | 2019-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.75 | 2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.83 | 2024 | Jardiance |
| Abbvie INC. | $16.42 | 2021 | |
| Boston Scientific Corporation | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Darnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.